Ardsley Advisory Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-261,100
Closed -$3.1M 146
2024
Q4
$3.1M Buy
261,100
+136,100
+109% +$2.32M 0.49% 70
2024
Q3
$3.46M Sell
125,000
-270,000
-68% -$6.76M 0.57% 61
2024
Q2
$9.42M Sell
395,000
-470,000
-54% -$11M 1.38% 19
2024
Q1
$15.2M Sell
865,000
-181,000
-17% -$2.67M 2.19% 11
2023
Q4
$16.5M Sell
1,046,000
-499,000
-32% -$5.15M 2.55% 9
2023
Q3
$13.3M Buy
1,545,000
+33,322
+2% +$237K 2.97% 7
2023
Q2
$11.9M Buy
1,511,678
+765,678
+103% +$5.33M 2.02% 10
2023
Q1
$5.56M Buy
746,000
+437,500
+142% +$4.35M 1.22% 32
2022
Q4
$3.64M Buy
+308,500
New +$3.53M 0.75% 33
2022
Q3
Sell
-100,500
Closed -$999K 107
2022
Q2
$999K Buy
+100,500
New +$2.03M 0.16% 79
2021
Q3
Sell
-50,500
Closed -$1.51M 133
2021
Q2
$1.51M Buy
+50,500
New +$1.03M 0.18% 77

Other funds holding ASPN

Ardsley Advisory Partners's ASPN Position: Q1 2025 in Review

Ardsley Advisory Partners sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 261,100 shares — an estimated $3.1M sold.

Ardsley Advisory Partners first reported a position in ASPN in Q2 2021 and held it in 11 quarters. The position peaked at $16.5M in Q4 2023. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Ardsley Advisory Partners reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Ardsley Advisory Partners sold 261,100 Aspen Aerogels shares in Q1 2025, an estimated $3.1M.
  • Ardsley Advisory Partners first reported a position in Aspen Aerogels in Q2 2021 and held it in 11 quarters.
  • Ardsley Advisory Partners's Aspen Aerogels position peaked at $16.5M in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Ardsley Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.